These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17221928)

  • 1. A rapid method for quantitatively estimating metabolites in human plasma in the absence of synthetic standards using a combination of liquid chromatography/mass spectrometry and radiometric detection.
    Yu C; Chen CL; Gorycki FL; Neiss TG
    Rapid Commun Mass Spectrom; 2007; 21(4):497-502. PubMed ID: 17221928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
    Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
    Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-dimensional liquid chromatography/mass spectrometry set-up for structural elucidation of metabolites in complex biological matrices.
    Kiffe M; Graf D; Trunzer M
    Rapid Commun Mass Spectrom; 2007; 21(6):961-70. PubMed ID: 17299833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method for rapid metabolite profiling of drug candidates in fresh hepatocytes using liquid chromatography coupled with a hybrid quadrupole linear ion trap.
    Gao H; Materne OL; Howe DL; Brummel CL
    Rapid Commun Mass Spectrom; 2007; 21(22):3683-93. PubMed ID: 17937450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative estimation of circulating metabolites without synthetic standards by ultra-high-performance liquid chromatography/high resolution accurate mass spectrometry in combination with UV correction.
    Yang Y; Grubb MF; Luk CE; Humphreys WG; Josephs JL
    Rapid Commun Mass Spectrom; 2011 Nov; 25(21):3245-51. PubMed ID: 22006386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies.
    Tiller PR; Yu S; Bateman KP; Castro-Perez J; McIntosh IS; Kuo Y; Baillie TA
    Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3510-6. PubMed ID: 18853407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of parent drug and its unstable metabolites by in situ coulometric oxidation and liquid chromatography-tandem mass spectrometry.
    Tong W; Chowdhury SK; Su AD; Alton KB
    Anal Chem; 2010 Dec; 82(24):10251-7. PubMed ID: 21105697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined approach for high-throughput preparation and analysis of plasma samples from exposure studies.
    Briem S; Martinsson S; Bueters T; Skoglund E
    Rapid Commun Mass Spectrom; 2007; 21(13):1965-72. PubMed ID: 17526069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of drug metabolites in the absence of pure metabolite standards by high-performance liquid chromatography coupled with a chemiluminescence nitrogen detector and mass spectrometer.
    Deng Y; Wu JT; Zhang H; Olah TV
    Rapid Commun Mass Spectrom; 2004; 18(15):1681-5. PubMed ID: 15282765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of relative LC/MS response of metabolites to parent drug in LC/nanospray ionization mass spectrometry: potential implications in MIST assessment.
    Schadt S; Chen LZ; Bischoff D
    J Mass Spectrom; 2011 Dec; 46(12):1281-6. PubMed ID: 22223420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An algorithm for thorough background subtraction from high-resolution LC/MS data: application to the detection of troglitazone metabolites in rat plasma, bile, and urine.
    Zhang H; Ma L; He K; Zhu M
    J Mass Spectrom; 2008 Sep; 43(9):1191-200. PubMed ID: 18521834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation and quantification of two diastereomers of a Drug Candidate in rat plasma by ultra-high pressure liquid chromatography/mass spectrometry.
    Wang H; Edom RW; Kumar S; Vincent S; Shen Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):26-34. PubMed ID: 17442640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-low flow nanospray for the normalization of conventional liquid chromatography/mass spectrometry through equimolar response: standard-free quantitative estimation of metabolite levels in drug discovery.
    Valaskovic GA; Utley L; Lee MS; Wu JT
    Rapid Commun Mass Spectrom; 2006; 20(7):1087-96. PubMed ID: 16506151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments.
    Gao H; Deng S; Obach RS
    Drug Metab Dispos; 2010 Dec; 38(12):2147-56. PubMed ID: 20847138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry.
    Balani SK; Nagaraja NV; Qian MG; Costa AO; Daniels JS; Yang H; Shimoga PR; Wu JT; Gan LS; Lee FW; Miwa GT
    Drug Metab Dispos; 2006 Mar; 34(3):384-8. PubMed ID: 16326814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting circulating human metabolites: how good are we?
    Anderson S; Luffer-Atlas D; Knadler MP
    Chem Res Toxicol; 2009 Feb; 22(2):243-56. PubMed ID: 19138063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of a nanosplitter interface into an LC-MS-RD system to facilitate drug metabolism studies.
    Andrews CL; Li F; Yang E; Yu CP; Vouros P
    J Mass Spectrom; 2006 Jan; 41(1):43-9. PubMed ID: 16317713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of exposure multiples of human metabolites for MIST assessment in preclinical safety species without using reference standards or radiolabeled compounds.
    Ma S; Li Z; Lee KJ; Chowdhury SK
    Chem Res Toxicol; 2010 Dec; 23(12):1871-3. PubMed ID: 21121646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of relative 12C/14C isotope ratios to estimate metabolite concentrations in the absence of authentic standards.
    Cuyckens F; Pauwels N; Koppen V; Leclercq L
    Bioanalysis; 2012 Jan; 4(2):143-56. PubMed ID: 22250797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of drugs in plasma without primary reference standards by liquid chromatography-chemiluminescence nitrogen detection: application to tramadol metabolite ratios.
    Ojanperä S; Rasanen I; Sistonen J; Pelander A; Vuori E; Ojanperä I
    Ther Drug Monit; 2007 Aug; 29(4):423-8. PubMed ID: 17667796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.